Table 1.
Patients’ characteristics
| Gender | |
| Male | 14 (41.2%) |
| Female | 20 (58.8%) |
| Total | 34 (100%) |
| Age (years) | |
| Range | 27–82 |
| Mean (±SD) | 57.7 (±12.4) |
| Median | 59 |
| Primary cancer | |
| Gastric | 6 (17.6%) |
| Lung | 5 (14.7%) |
| Colorectal | 4 (11.8%) |
| Lymphoma | 4 (11.8%) |
| Breast | 3 (8.8%) |
| Ovarian | 3 (8.8%) |
| Melanoma | 2 (5.9%) |
| Others | 7 (20.6%) |
| Indication for CT | |
| Initial staging | 4 (11.8%) |
| Response evaluation | 22 (64.7%) |
| Surveillance of metastasis | 8 (23.5%) |
| Stage | |
| I | 1 (2.9%) |
| II | 2 (5.9%) |
| III | 5 (14.7%) |
| IV | 26 (76.5%) |
| Oncologic treatment | |
| Chemotherapy | 23 (67.6%) |
| Radiotherapy | 4 (11.8%) |
| Hormonal therapy | 0 (0.0%) |
| None | 7 (20.6%) |